Biocon Ltd. — Capital/Financing Update 2023

May 19, 2023

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

BIO/SECL/AJ/2023-24/26

May 19, 2023

May 19, 2023
To, The Secretary BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street,Mumbai – 400 001	To, The Secretary National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol - BIOCON

Subject: Allotment of Non-Convertible Debentures on private placement basis

Dear Sir/ Madam,

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our letter dated April 26, 2023, we wish to inform you that the Company has issued and allotted 50,000 unlisted, secured, redeemable, non-convertible debentures of face value of INR 1,00,000/- (Rupees One Lakh only) each on private placement basis, having an aggregate nominal value of INR 5,00,00,00,000 (Rupees Five Hundred Crores Only) on the terms and conditions given below-

Sl. No.	Particulars	Remarks
1.	Type of securities issued / allotted (viz. equity shares,convertibles etc.)	Non-Convertible Debentures (NCDs)
2.	Type of issuance (further public offering, rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.)	Private Placement
3.	Total number of securities issued/allotted	50,000(FiftyThousand)NCDs
4.	Issue Size / the total amount for which the securities have been issued/allotted	Rs. 5,00,00,00,000 (Rupees Five Hundred Crores Only)
5.	Number of Investor	2(Two)
6.	Name of Investor	1. ESOF III Investment Fund 2. Edelweiss Alternative Asset Advisors Limited
7.	Outcome of the subscription	Fullysubscribed
8.	Issue Price/Allotted Priceper security	Rs. 1,00,000/-per NCD
9.	Whether proposed to be listed? If yes, name of the stock exchange	No
10.	Tenure of the instrument	4(four) years from the date of allotment
11.	Date of Allotment	May19,2023
12.	Date of Maturity	May19,2027

==> picture [132 x 52] intentionally omitted <==

13.	Coupon/Interest offered	Coupon: Nil Redemption Premium will be payable on each Redemption Date in accordance with the provisions of the Debenture Trust Deed
14.	Schedule of payment of coupon/interest and principal	Upon Redemption
15.	Charge/security, if any, created over the assets	The Debentures and the Obligations shall be secured by a first ranking exclusive charge by way of pledge over the Pledged Shares at all times on and from the Date of Allotment until: (i) the date of consummation of the IPO Event subject to Clause 6.3 under the Debenture Trust Deed; or (ii) the Final Settlement Date, whichever is earlier. “Pledged Shares” means the (i) Initial Pledged Shares, and (ii) any additional Shares required to be pledged by the Company, from time to time, in accordance with the terms of the Pledge Agreement. “Initial Pledged Shares” means the 1,78,10,073 Shares of Biocon Biologics Limited (calculated on a fully diluted basis), pledged by the Company in favour of the Debenture Trustee in the manner contemplated under the Pledge Agreement
16.	Special rights/interest/privileges attached to the instrument and changes thereof	Call and Put options exercisable as per the terms of the debenture trust deed
17.	Delay in payment of interest/ principal amount for a period of more than 3 months from the due date or default in payment of interest/principal	Not Applicable
18.	Details of any letter or comments regarding payment/non-payment of interest, principal on due dates, or any other matter concerning the security and/or the assets along with its comments thereon,if any	Not Applicable
19.	Details of redemption of debentures	Redemption as per the terms of Debenture Trust Deed
20.	Any cancellation or termination of proposal for issuance of securities includingreasons thereof	Not Applicable

The aforesaid information will also be available on the website of the Company at www.biocon.com.

We request you to take this on record.

Thanking You, Yours faithfully,

For Biocon Limited

Digitally signed MAYAN by MAYANK VERMA K VERMA Date: 2023.05.19 17:38:34 +05'30' Mayank Verma Company Secretary and Compliance Officer Membership No.: ACS 18776